TY - JOUR AU - Watts, R. AU - Mahr, A. AU - Mohammad, A. PY - 2015 DA - 2015// TI - Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis JO - Nephrol Dial Transplant VL - 30 UR - https://doi.org/10.1093/ndt/gfv022 DO - 10.1093/ndt/gfv022 ID - Watts2015 ER - TY - JOUR AU - Schönermarck, U. AU - Csernok, E. AU - Gross, W. L. PY - 2015 DA - 2015// TI - Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis: challenges and solutions 2014 JO - Nephrol Dial Transplant VL - 30 UR - https://doi.org/10.1093/ndt/gfu398 DO - 10.1093/ndt/gfu398 ID - Schönermarck2015 ER - TY - JOUR AU - Van der Woude, F. J. AU - Rasmussen, N. AU - Lobatto, S. PY - 1995 DA - 1995// TI - Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity inWegener’sgranulomatosis JO - Lancet VL - 1 ID - Van der Woude1995 ER - TY - JOUR AU - Mahr, A. AU - Katsahian, S. AU - Varet, H. PY - 2013 DA - 2013// TI - Revisiting the classification of clinicalphenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis JO - Ann Rheum Dis VL - 72 UR - https://doi.org/10.1136/annrheumdis-2012-201750 DO - 10.1136/annrheumdis-2012-201750 ID - Mahr2013 ER - TY - JOUR AU - Westman, K. AU - Flossmann, O. AU - Gregorini, G. PY - 2015 DA - 2015// TI - The long term outcome of systemic vasculitis JO - Nephrol Dial Transplant VL - 30 UR - https://doi.org/10.1093/ndt/gfu392 DO - 10.1093/ndt/gfu392 ID - Westman2015 ER - TY - JOUR AU - Joode, A. A. E. AU - Sanders, J. S. F. AU - Stegeman, C. A. PY - 2013 DA - 2013// TI - Renal Survival in Proteinase 3 and Myeloperoxidase ANCA-Associated Systemic Vasculitis JO - Clin J Am Soc Nephrol VL - 8 UR - https://doi.org/10.2215/CJN.01020113 DO - 10.2215/CJN.01020113 ID - Joode2013 ER - TY - JOUR AU - Westman, K. AU - Flossmann, O. AU - Gregorini, G. PY - 2015 DA - 2015// TI - The long-term outcomes of systemic vasculitis JO - Nephrol Dial Transplant VL - 30 UR - https://doi.org/10.1093/ndt/gfu392 DO - 10.1093/ndt/gfu392 ID - Westman2015 ER - TY - JOUR AU - Hogan, S. L. AU - Nachman, P. H. AU - Wilkman, A. S. PY - 1996 DA - 1996// TI - Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis JO - J Am Soc Nephrol VL - 7 ID - Hogan1996 ER - TY - JOUR AU - Koldingsnes, W. AU - Nossent, H. PY - 2002 DA - 2002// TI - Predictors of survival and organ damage in Wegener’s granulomatosis JO - Rheumatology VL - 41 UR - https://doi.org/10.1093/rheumatology/41.5.572 DO - 10.1093/rheumatology/41.5.572 ID - Koldingsnes2002 ER - TY - JOUR AU - Little, M. A. AU - Nightingale, P. AU - Verburgh, C. A. PY - 2010 DA - 2010// TI - Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis JO - Ann Rheum Dis VL - 69 UR - https://doi.org/10.1136/ard.2009.109389 DO - 10.1136/ard.2009.109389 ID - Little2010 ER - TY - JOUR AU - Wall, N. AU - Harper, L. PY - 2012 DA - 2012// TI - Complications of long –term therapy for ANCA-associated systemic vasculitis JO - Nat Rev Nephrol Sep VL - 8 UR - https://doi.org/10.1038/nrneph.2012.107 DO - 10.1038/nrneph.2012.107 ID - Wall2012 ER - TY - JOUR AU - Presta, P. AU - Fuiano, G. AU - Lombardi, G. PY - 2015 DA - 2015// TI - Successful conception and pregnancy in p-ANCA-associated vasculitis in course of treatment with immunosuppressive drugs and renal replacement therapy JO - Int J Rheum Dis VL - 18 UR - https://doi.org/10.1111/1756-185X.12454 DO - 10.1111/1756-185X.12454 ID - Presta2015 ER - TY - JOUR AU - Shonermarck, U. AU - Gross, W. L. AU - Groot, K. PY - 2014 DA - 2014// TI - Treatment of ANCA-associated vasculitis JO - Nat Rev Nephrol VL - 10 UR - https://doi.org/10.1038/nrneph DO - 10.1038/nrneph ID - Shonermarck2014 ER - TY - JOUR AU - Stone, J. H. AU - Merkel, P. A. AU - Spiera, R. PY - 2010 DA - 2010// TI - Rituximab versus cyclophosphamide for ANCA-associatedvasculitis JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMoa0909905 DO - 10.1056/NEJMoa0909905 ID - Stone2010 ER - TY - JOUR AU - Jones, R. B. AU - Tervaert, J. W. AU - Hauser, T. PY - 2010 DA - 2010// TI - Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMoa0909169 DO - 10.1056/NEJMoa0909169 ID - Jones2010 ER - TY - JOUR AU - Shah, S. AU - Hruskova, Z. AU - Segelmark, M. PY - 2015 DA - 2015// TI - Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab JO - Am J Nephrol VL - 41 UR - https://doi.org/10.1159/000431336 DO - 10.1159/000431336 ID - Shah2015 ER - TY - JOUR AU - Geetha, D. AU - Specks, U. AU - Stone, J. H. PY - 2015 DA - 2015// TI - Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement JO - J Am SocNephrol VL - 26 ID - Geetha2015 ER - TY - JOUR AU - Geetha, D. AU - Hruskova, Z. AU - Segelmark, M. PY - 2016 DA - 2016// TI - Rituximab for treatment of severe renal disease in ANCA associated vasculitis JO - J Nephrol VL - 29 UR - https://doi.org/10.1007/s40620-015-0208-y DO - 10.1007/s40620-015-0208-y ID - Geetha2016 ER - TY - JOUR AU - Radhakrishnan, J. AU - CattranDC PY - 2012 DA - 2012// TI - The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines--application to the individual patient JO - Kidney Int VL - 82 UR - https://doi.org/10.1038/ki.2012.280 DO - 10.1038/ki.2012.280 ID - Radhakrishnan2012 ER - TY - JOUR AU - Unizony, S. AU - Villarreal, M. AU - Miloslavsky, E. M. PY - 2016 DA - 2016// TI - Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associatedvasculitis based on ANCA type JO - Ann Rheum Dis VL - 75 UR - https://doi.org/10.1136/annrheumdis-2015-208073 DO - 10.1136/annrheumdis-2015-208073 ID - Unizony2016 ER - TY - JOUR AU - Brix, S. R. AU - Noriega, M. AU - Tennstedt, P. PY - 2018 DA - 2018// TI - Development and validation of a renal risk score in ANCA-associated glomerulonephritis JO - Kidney Int VL - 94 UR - https://doi.org/10.1016/j.kint.2018.07.020 DO - 10.1016/j.kint.2018.07.020 ID - Brix2018 ER - TY - JOUR AU - Kronbichler, A. AU - Jayne, D. R. W. PY - 2018 DA - 2018// TI - ANCA Renal risk score: is prediction of end-stage renal disease at baseline possible? JO - Kidney Int VL - 94 UR - https://doi.org/10.1016/j.kint.2018.10.001 DO - 10.1016/j.kint.2018.10.001 ID - Kronbichler2018 ER - TY - JOUR AU - Itabashi, M. AU - Takei, T. AU - Moriyama, T. PY - 2014 DA - 2014// TI - Long-term damage assessment in patients with microscopic polyangiitis and renal-limited vasculitis using the Vasculitis damage index JO - Mod Rheumatol VL - 24 UR - https://doi.org/10.3109/14397595.2013.852836 DO - 10.3109/14397595.2013.852836 ID - Itabashi2014 ER - TY - JOUR AU - King, C. AU - Harper, L. PY - 2017 DA - 2017// TI - Avoidance of harm from treatment for ANCA-associated vasculitis JO - Curr Treatm Opt Rheumatol VL - 3 UR - https://doi.org/10.1007/s40674-017-0082-y DO - 10.1007/s40674-017-0082-y ID - King2017 ER - TY - STD TI - McAdoo SP, Medjeral-Thomas N, Gopaluni S, et al. Long-term follow-up of a combined rituximab and cyclophosphamide regimen in anti-neutrophil cytoplasm antibody-associated vasculitis. Nephrol Dial Transplant. 2018;33(5):899. ID - ref25 ER -